health

A report of the Aspen Health Strategy Group. This book is a collection of papers on the group’s third subject: prevention of chronic disease.

To meet its vast responsibilities for more than $2.5 trillion in products, the FDA should operate from a structure that best accommodates rigorous, science-based decisionmaking. This White Paper documents the growing demands on the agency and current barriers to regulatory efficiency, and provides supporting evidence for the Commissioners’ consensus recommendation on a two-step pathway to independence.

In June 2016, six former Commissioners of the Food and Drug Administration convened at Aspen Ideas: Health (previously Spotlight Health) to talk about the challenges facing the FDA. From that stage, they publicly announced their consensus view that the FDA should be transformed into an independent federal agency.

To help public health leaders effectively communicate the value of public health to potential partners and decision makers in other sectors, the de Beaumont Foundation and the Aspen Institute’s Health, Medicine and Society Program have launched PHRASES (Public Health Reaching Across Sectors).

Dan Buettner explains what we can learn from communities where people live the longest.

Connecticut's Office of Early Childhood unveiled a new program to support children and their parents.